Sana Biotechnology, Inc (SANA) insider trading
Every open-market stock purchase and sale by Sana Biotechnology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Flagship Pioneering Inc. (Insider), $15M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $4.09 on Aug 27, 2026.
Recent SANA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 27, 2026 | Dhavalkumar Dhirajlal Patel (C-suite exec) | Sold (not open market) | $169K |
| Aug 26, 2026 | Dhavalkumar Dhirajlal Patel (C-suite exec) | Bought (not open market) | — |
| Jul 6, 2026 | Hans Edgar Bishop (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Michelle Seitz (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Alise Reicin (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Patrick Y Yang (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Robert L. Rosiello (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Hans Edgar Bishop (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Richard Mulligan (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Jun 4, 2026 | Joshua H. Bilenker (Insider) | Bought (not open market) | — |
| Apr 6, 2026 | Hans Edgar Bishop (Insider) | Bought (not open market) | — |
| Mar 9, 2026 | Steve Harr (CEO) | Sold (not open market) | $39.7K |
| Mar 9, 2026 | Steve Harr (CEO) | Sold (not open market) | $36.1K |
| Mar 9, 2026 | Susan D. Wyrick (Insider) | Sold (not open market) | $10.5K |
| Mar 9, 2026 | Susan D. Wyrick (Insider) | Sold (not open market) | $3.2K |
| Mar 7, 2026 | Susan D. Wyrick (Insider) | Bought (not open market) | — |
| Mar 7, 2026 | Steve Harr (CEO) | Bought (not open market) | — |
| Mar 6, 2026 | Susan D. Wyrick (Insider) | Bought (not open market) | — |
| Mar 6, 2026 | Steve Harr (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | Steve Harr (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | Susan D. Wyrick (Insider) | Bought (not open market) | — |
| Mar 5, 2026 | Susan D. Wyrick (Insider) | Bought (not open market) | — |
| Mar 5, 2026 | Steve Harr (CEO) | Bought (not open market) | — |
| Mar 3, 2026 | Susan D. Wyrick (Insider) | Sold (not open market) | $1.9K |
Who's trading SANA
- Dhavalkumar Dhirajlal Patel, C-suite exec: other filings, last Aug 27, 2026
- Hans Edgar Bishop, Insider: other filings, last Jul 6, 2026
- Patrick Y Yang, Insider: other filings, last Jun 4, 2026
- Joshua H. Bilenker, Insider: other filings, last Jun 4, 2026
- Richard Mulligan, Insider: other filings, last Jun 4, 2026
- Robert Nelsen, 10% owner: other filings, last Jun 4, 2026
- Alise Reicin, Insider: other filings, last Jun 4, 2026
- Robert L. Rosiello, Insider: other filings, last Jun 4, 2026
- Michelle Seitz, Insider: other filings, last Jun 4, 2026
- Susan D. Wyrick, Insider: other filings, last Mar 9, 2026
- Steve Harr, CEO: other filings, last Mar 9, 2026
- Brian Piper, CFO: other filings, last Feb 17, 2026
Get free alerts when an insider at Sana Biotechnology, Inc files a new trade →